🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

1,187 results for “Takeda” Clear

  1. Vedolizumab IV

    Takeda

    Crohn's Disease (CD)

    phase 3 small molecule active

    1 trial

  2. Vedolizumab IV

    Takeda

    Crohn's Disease

    phase 3 small molecule active

    2 trials

  3. Vedolizumab IV

    Takeda

    Ulcerative Colitis

    phase 3 small molecule active

    4 trials

  4. Vedolizumab Placebo

    Takeda

    Hematopoietic Stem Cells

    phase 3 small molecule completed

    1 trial

  5. Vedolizumab SC

    Takeda

    Colitis, Ulcerative

    phase 3 small molecule completed

    1 trial

  6. Vedolizumab SC

    Takeda

    Ulcerative Colitis

    phase 3 small molecule active

    1 trial

  7. Vedolizumab SC 108 mg

    Takeda

    Crohn's Disease

    phase 3 small molecule completed

    1 trial

  8. Venticute

    Takeda

    Pneumonia

    phase 3 small molecule completed

    1 trial

  9. Vonicog Alfa

    Takeda

    Von Willebrand Disease (VWD)

    phase 3 mab active

    1 trial

  10. Vonicog alfa

    Takeda

    Von Willebrand Disease

    phase 3 mab completed

    1 trial

  11. Vonoprazan

    Takeda

    Healthy Volunteers

    phase 3 small molecule completed

    1 trial

  12. Vonoprazan

    Takeda

    Helicobacter Pylori

    phase 3 small molecule completed

    1 trial

  13. Vortioxetine

    Takeda

    Treatment Outcome

    phase 3 small molecule completed

    1 trial

  14. Vortioxetine

    Takeda

    Major Depressive Disorder

    phase 3 small molecule completed

    9 trials

  15. Vortioxetine

    Takeda

    Depressive Disorder, Major

    phase 3 small molecule completed

    5 trials

  16. Vortioxetine

    Takeda

    TBI

    phase 3 small molecule terminated

    1 trial

  17. Vortioxetine

    Takeda

    Generalized Anxiety Disorder

    phase 3 small molecule completed

    3 trials

  18. Vortioxetine 10 mg/day

    Takeda

    Depressive Disorder, Major

    phase 3 small molecule completed

    2 trials

  19. Vortioxetine tablets

    Takeda

    Major Depressive Disorder

    phase 3 small molecule active

    1 trial

  20. Vyvanse (lisdexamfetamine dimesylate)

    Takeda

    ADHD

    phase 3 small molecule completed

    1 trial

  21. YF-17D

    Takeda

    Dengue

    phase 3 mab completed

    1 trial

  22. ZASOCITINIB

    Takeda

    Moderate to Severe Plaque Psoriasis

    phase 3 small molecule active

    1 trial

  23. Zasocitinib

    Takeda

    Psoriatic Arthritis

    phase 3 small molecule active

    3 trials

  24. Zasocitinib

    Takeda

    Plaque Psoriasis

    phase 3 small molecule active

    2 trials

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources